Speaker(s): 

Elizabeth Profeta, MD, Pediatric Critical Care Medicine, Geisinger - has nothing to disclose.

Moderator(s): 

Ronald Wong, MD, Director Pediatric Critical Care, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Reflect on your current practices regarding ketamine for procedural sedation
• Identify the current clinical concerns/complications with ketamine for pediatric procedural sedation
• Review the new literature adding significant power to what is known about the risks with ketamine sedation in pediatrics
• Recognize the highest risk factor for any adverse event associated with ketamine pediatric procedural sedation

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Ronald Wong, D.O. and Kristine Savage, R.N. have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None